{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 359.93, "width": 2306, "height": 1728, "unit": "pixel", "lines": [{"boundingBox": [70, 17, 68, 98, 40, 97, 41, 18], "text": "Order", "words": [{"boundingBox": [69, 24, 68, 97, 39, 96, 40, 23], "text": "Order"}]}, {"boundingBox": [103, 22, 97, 530, 64, 529, 70, 21], "text": "Confidential Pursuant to Confidentiality", "words": [{"boundingBox": [103, 24, 102, 179, 69, 179, 70, 26], "text": "Confidential"}, {"boundingBox": [102, 186, 101, 304, 68, 304, 69, 186], "text": "Pursuant"}, {"boundingBox": [101, 311, 101, 336, 67, 336, 68, 311], "text": "to"}, {"boundingBox": [101, 343, 97, 530, 65, 529, 67, 343], "text": "Confidentiality"}]}, {"boundingBox": [298, 173, 1319, 174, 1318, 256, 297, 254], "text": "Clinical Trial Publications", "words": [{"boundingBox": [303, 177, 610, 174, 609, 252, 303, 256], "text": "Clinical"}, {"boundingBox": [625, 174, 802, 174, 801, 251, 625, 252], "text": "Trial"}, {"boundingBox": [818, 174, 1316, 180, 1315, 256, 817, 251], "text": "Publications"}]}, {"boundingBox": [360, 438, 558, 437, 559, 478, 361, 479], "text": "ARTICLE", "words": [{"boundingBox": [367, 439, 554, 439, 554, 477, 367, 480], "text": "ARTICLE"}]}, {"boundingBox": [845, 440, 1043, 437, 1044, 476, 846, 479], "text": "AUTHORS", "words": [{"boundingBox": [846, 440, 1043, 438, 1041, 476, 846, 478], "text": "AUTHORS"}]}, {"boundingBox": [1224, 438, 1417, 436, 1418, 476, 1225, 479], "text": "JOURNAL", "words": [{"boundingBox": [1225, 439, 1418, 437, 1418, 478, 1225, 480], "text": "JOURNAL"}]}, {"boundingBox": [1488, 436, 1691, 436, 1691, 477, 1489, 478], "text": "STATUS", "words": [{"boundingBox": [1494, 438, 1663, 437, 1663, 478, 1496, 478], "text": "STATUS"}]}, {"boundingBox": [1692, 436, 1856, 439, 1855, 478, 1691, 476], "text": "TIMING", "words": [{"boundingBox": [1712, 438, 1849, 439, 1849, 477, 1712, 476], "text": "TIMING"}]}, {"boundingBox": [362, 485, 725, 484, 726, 523, 363, 525], "text": "Effect of PREMARIN/", "words": [{"boundingBox": [366, 487, 466, 486, 466, 524, 367, 525], "text": "Effect"}, {"boundingBox": [473, 486, 506, 486, 506, 524, 473, 524], "text": "of"}, {"boundingBox": [513, 486, 726, 485, 725, 524, 513, 524], "text": "PREMARIN/"}]}, {"boundingBox": [835, 487, 914, 488, 912, 523, 835, 524], "text": "TBD", "words": [{"boundingBox": [839, 486, 911, 486, 911, 523, 839, 523], "text": "TBD"}]}, {"boundingBox": [1217, 485, 1297, 487, 1297, 522, 1217, 522], "text": "TBD", "words": [{"boundingBox": [1221, 485, 1290, 485, 1290, 522, 1221, 522], "text": "TBD"}]}, {"boundingBox": [1490, 490, 1975, 487, 1975, 523, 1491, 527], "text": "In progress To be submitted", "words": [{"boundingBox": [1493, 491, 1524, 491, 1524, 526, 1493, 527], "text": "In"}, {"boundingBox": [1534, 491, 1685, 491, 1684, 524, 1533, 526], "text": "progress"}, {"boundingBox": [1713, 491, 1753, 491, 1753, 523, 1713, 524], "text": "To"}, {"boundingBox": [1760, 491, 1805, 490, 1805, 523, 1760, 523], "text": "be"}, {"boundingBox": [1815, 490, 1975, 487, 1975, 524, 1814, 523], "text": "submitted"}]}, {"boundingBox": [364, 530, 798, 529, 799, 573, 365, 573], "text": "trimegestone on quality of", "words": [{"boundingBox": [366, 533, 587, 533, 588, 571, 365, 571], "text": "trimegestone"}, {"boundingBox": [594, 533, 639, 533, 640, 571, 596, 571], "text": "on"}, {"boundingBox": [646, 533, 757, 531, 759, 573, 648, 572], "text": "quality"}, {"boundingBox": [764, 530, 796, 530, 799, 574, 766, 573], "text": "of"}]}, {"boundingBox": [1707, 530, 1853, 531, 1852, 569, 1706, 567], "text": "Q2 2002", "words": [{"boundingBox": [1709, 532, 1761, 531, 1761, 567, 1709, 568], "text": "Q2"}, {"boundingBox": [1770, 532, 1853, 533, 1854, 570, 1771, 567], "text": "2002"}]}, {"boundingBox": [363, 576, 416, 576, 414, 612, 360, 613], "text": "life", "words": [{"boundingBox": [364, 575, 413, 575, 414, 612, 364, 612], "text": "life"}]}, {"boundingBox": [358, 661, 737, 662, 736, 699, 357, 698], "text": "Endometrial effects of", "words": [{"boundingBox": [366, 662, 569, 664, 570, 700, 365, 698], "text": "Endometrial"}, {"boundingBox": [576, 664, 691, 664, 692, 699, 577, 700], "text": "effects"}, {"boundingBox": [698, 664, 735, 663, 737, 698, 699, 699], "text": "of"}]}, {"boundingBox": [829, 661, 913, 661, 912, 698, 830, 698], "text": "TBD", "words": [{"boundingBox": [841, 661, 910, 661, 910, 698, 841, 698], "text": "TBD"}]}, {"boundingBox": [1217, 661, 1297, 661, 1296, 697, 1215, 697], "text": "TBD", "words": [{"boundingBox": [1222, 661, 1291, 661, 1291, 697, 1222, 697], "text": "TBD"}]}, {"boundingBox": [1487, 661, 1974, 660, 1975, 699, 1488, 700], "text": "In progress To be submitted", "words": [{"boundingBox": [1491, 661, 1525, 662, 1525, 701, 1491, 701], "text": "In"}, {"boundingBox": [1533, 662, 1685, 664, 1686, 699, 1533, 701], "text": "progress"}, {"boundingBox": [1711, 665, 1751, 665, 1752, 699, 1712, 699], "text": "To"}, {"boundingBox": [1759, 665, 1806, 665, 1807, 699, 1760, 699], "text": "be"}, {"boundingBox": [1814, 665, 1974, 663, 1976, 698, 1815, 699], "text": "submitted"}]}, {"boundingBox": [359, 701, 795, 706, 794, 745, 359, 741], "text": "PREMARIN/trimegestone", "words": [{"boundingBox": [366, 702, 791, 708, 793, 744, 365, 742], "text": "PREMARIN/trimegestone"}]}, {"boundingBox": [1690, 703, 1847, 705, 1846, 743, 1689, 741], "text": "Q2 2002", "words": [{"boundingBox": [1707, 705, 1761, 705, 1760, 742, 1707, 741], "text": "Q2"}, {"boundingBox": [1768, 705, 1846, 706, 1845, 743, 1767, 742], "text": "2002"}]}, {"boundingBox": [361, 792, 716, 791, 717, 830, 362, 831], "text": "Bleeding profiles with", "words": [{"boundingBox": [366, 792, 515, 795, 514, 832, 364, 831], "text": "Bleeding"}, {"boundingBox": [523, 795, 646, 795, 646, 831, 522, 832], "text": "profiles"}, {"boundingBox": [654, 795, 718, 794, 718, 830, 653, 831], "text": "with"}]}, {"boundingBox": [833, 790, 913, 790, 911, 826, 834, 827], "text": "TBD", "words": [{"boundingBox": [840, 789, 909, 789, 909, 826, 840, 826], "text": "TBD"}]}, {"boundingBox": [1215, 792, 1298, 790, 1297, 826, 1215, 827], "text": "TBD", "words": [{"boundingBox": [1221, 790, 1288, 789, 1289, 825, 1222, 826], "text": "TBD"}]}, {"boundingBox": [1484, 794, 1977, 791, 1978, 829, 1485, 832], "text": "In progress To be submitted", "words": [{"boundingBox": [1490, 795, 1524, 795, 1524, 832, 1491, 832], "text": "In"}, {"boundingBox": [1531, 795, 1684, 794, 1684, 829, 1532, 831], "text": "progress"}, {"boundingBox": [1710, 794, 1752, 793, 1752, 829, 1710, 829], "text": "To"}, {"boundingBox": [1759, 793, 1805, 793, 1805, 829, 1759, 829], "text": "be"}, {"boundingBox": [1812, 793, 1977, 793, 1976, 830, 1812, 829], "text": "submitted"}]}, {"boundingBox": [356, 833, 795, 837, 794, 876, 356, 873], "text": "PREMARIN/trimegestone", "words": [{"boundingBox": [365, 834, 794, 839, 794, 876, 364, 873], "text": "PREMARIN/trimegestone"}]}, {"boundingBox": [1700, 837, 1849, 838, 1848, 873, 1699, 872], "text": "Q2 2002", "words": [{"boundingBox": [1707, 837, 1761, 839, 1761, 873, 1707, 873], "text": "Q2"}, {"boundingBox": [1768, 839, 1848, 839, 1849, 872, 1768, 873], "text": "2002"}]}, {"boundingBox": [92, 1424, 91, 1694, 58, 1693, 59, 1423], "text": "CONTA204-000905", "words": [{"boundingBox": [92, 1431, 91, 1693, 59, 1692, 59, 1431], "text": "CONTA204-000905"}]}, {"boundingBox": [1823, 1509, 2011, 1506, 2012, 1563, 1824, 1566], "text": "Wyeth", "words": [{"boundingBox": [1831, 1510, 2009, 1508, 2011, 1563, 1834, 1567], "text": "Wyeth"}]}, {"boundingBox": [1913, 1565, 2128, 1568, 2127, 1598, 1912, 1595], "text": "Pharmaceuticals", "words": [{"boundingBox": [1916, 1566, 2127, 1569, 2127, 1598, 1917, 1596], "text": "Pharmaceuticals"}]}, {"boundingBox": [673, 1685, 1635, 1684, 1635, 1721, 674, 1722], "text": "Source: https://www.industrydocuments.ucsf.edu/docs/npbw0217", "words": [{"boundingBox": [674, 1686, 787, 1686, 786, 1722, 674, 1720], "text": "Source:"}, {"boundingBox": [793, 1686, 1635, 1684, 1635, 1721, 793, 1722], "text": "https://www.industrydocuments.ucsf.edu/docs/npbw0217"}]}]}]}